We are delighted to announce the promotion of Afan Swan to senior research data specialist, in effect as of June 1. Swan earned a bachelor's degree in microbiology and master's degree in public health from the University of Alabama, joining our department in 2021 as a health services research analyst. Swan's expertise has been vital to multicenter collaborations with the Investigating Respiratory Viruses in the Acutely Ill (IVY) Network, the Vanderbilt Biostatistics Data Coordinating Center, and elsewhere, and she has co-authored multiple peer-reviewed publications as a VUMC analyst, including the following:
- Surie D et al. Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Netw Open. 2024 Apr 1;7(4):e244954. doi: 10.1001/jamanetworkopen.2024.4954. PMID: 38573635.
- Raglow Z et al. SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis. Lancet Microbe. 2024 Mar;5(3):e235-e246. doi: 10.1016/S2666-5247(23)00336-1. Epub 2024 Jan 26. PMID: 38286131.
- DeCuir J et al. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 29;73(8):180-188. doi: 10.15585/mmwr.mm7308a5. PMID: 38421945; PMCID: PMC10907041.
- Lewis NM et al. Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 Apr 10;78(4):1056-1064. doi: 10.1093/cid/ciad677. PMID: 38051664.
- Kojima N et al. Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. Clin Infect Dis. 2023-08-22; 77(4):547-557. doi:10.1093/cid/ciad276. PubMed PMID: 37255285
- Dimcheff DE et al. Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. J Infect Dis. 2023 Aug 11;228(3):235-244. doi: 10.1093/infdis/jiad061. PMID: 36883903; PMCID: PMC10420395.
- Surie D et al. Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. Vaccine. 2023 Jun 29;41(29):4249-4256. doi: 10.1016/j.vaccine.2023.05.028. Epub 2023 May 15. PMID: 37301704; PMCID: PMC10183633.
- Tenforde MW et al. Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. Clin Infect Dis. 2023 Mar 21;76(6):1030-1037. doi: 10.1093/cid/ciac869. PMID: 36327388; PMCID: PMC10226741.
- Surie D et al. Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1327-1334. doi: 10.15585/mmwr.mm7142a3. PMID: 36264830; PMCID: PMC9590291.
Afan Swan (center) reports on a breakout discussion during a VBDCC meeting, May 2024